Category Archives: Medtonic Infuse

Featured Stories
Geodon the antipsychotic drug can Cause Deadly Skin Reaction

Geodon can Cause Deadly Skin Reaction, FDA Warns

The FDA has required a new warning label for the antipsychotic drug Geodon (ziprasidone) to include the risk of a potentially fatal skin reaction.

Read More

Do Vitamin Drinks Pose Health Risks?Do Vitamin Drinks Pose Health Risks?

Do Vitamin Drinks Pose Health Risks?

Scientists are concerned vitamin drinks are contributing to levels of vitamins and other nutrients that are not only unnecessary, but potentially harmful.

Read More

Image Source: saidaonline.com

Sleep Aids Can Increase Alzheimer’s Risk

A new study has found that over-the-counter sleeping aids and anti-allergy medicines can increase the risk of Alzheimer’s disease.

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Two Men Found Dead of Carbon Monoxide Poisoning

Two Men Found Dead of Carbon Monoxide Poisoning at Long Island, New York Auto Shop

Two men were found dead of apparent carbon monoxide poisoning in a Holbrook, New York, auto-detailing shop Thursday night, Suffolk County police say.

Read More

Actos Side Effects Lawyers Says Whistleblower Revelations Could Boost Bladder Cancer, Heart Failure Lawsuits

An attorney with a prominent personal injury law firm says an Actos whistleblower lawsuit filed earlier this year could strengthen legal claims alleging the type 2 diabetes medication caused some users to develop bladder cancer and heart failure.

Read More

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

System for Tracking Prescription Drug Side Effects Flawed

Study Finds System for Tracking Prescription Drug Side Effects Flawed

System for keeping track of dangerous side effects of prescription drugs is flawed because drug makers are submitting incomplete information about problems to the FDA.

Read More

FDA Warning for Bone Graft Products in Patients Under 18

FDA Safety Warning for Bone Graft Products in Patients Under 18

FDA issued safety alerts to patients, parents & guardians, bone graft devices w/recombinant proteins or synthetic peptides not to be the first treatment for 18 & under.

Read More

Estate of Kentucky Man Alleges Wrongful Death Due to Actos Bladder Cancer

National law firm, Parker Waichman LLP, just filed a lawsuit on behalf of the estate of a Kentucky man who developed bladder cancer and subsequently died, allegedly due to the use of diabetes drug, Actos. The lawsuit names Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, ...

Read More

Medtronic Infuse Recipients Receive $8.45 Million in Settlements

Medtronic Infuse Recipients Win $8.45 Million in Settlements

The University of California, Los Angeles has agreed to pay a combined $8.45 million to two patients who received Medtronic’s controversial Infuse bone graft product. These individuals filed lawsuits alleging that the product caused unwanted bone growth. They also claimed … Continue reading

Posted in Defective Medical Devices, Legal News, Medtonic Infuse | Tagged , , , , , , , , , , |

Medtronic Pays $500 Million Tax Charge To Move $9.8 Billion To United States

Medtronic Pays $500M Tax Charge To Move $9.8B To U.S.

As part of an internal restructuring related to its $49.9 billion merger with Covidien, Medtronic will pay a one-time tax charge of $500 million so that it can bring $9.8 billion in overseas cash to the United States. This move … Continue reading

Posted in Defective Medical Devices, Legal News, Medtonic Infuse | Tagged , , , , |

European Regulators Review Medtronic’s InductOs in Light of Contamination Issues

European Regulators Review Medtronic’s InductOs

The European Medicines Agency (EMA) will be reviewing Medtronic’s InductOs following reports of contamination problems at a site that manufacturers one of the product’s components. InductOs is an implantable bone development product used in patients undergoing spinal fusion in the … Continue reading

Posted in Legal News, Medtonic Infuse | Tagged , , , |

Federal Data Shows Medtronic Continues to Pay Doctors in Connection with InFuse Spinal Fusion Device

Federal Data Shows Medtronic Continues to Pay Doctors

Data available through the federal Open Payments database show that device maker Medtronic continues to pay millions of dollars to doctors whose research on the InFuse spinal fusion device has been called into question. Medtronic’s spine division, Medtronic Sofamor Danek, … Continue reading

Posted in Defective Medical Devices, Health Concerns, Medtonic Infuse | Tagged , , , , |

Study Reports Decline in Use of Bone Morphogenetic Proteins in Spinal Surgeries

Decline in Use of Bone Morphogenetic Proteins in Surgeries

Bone morphogenetic proteins (BMPs) have been widely used in spinal fusion surgeries since their approval in 2002, a new study published in the journal Spine says BMP use has declined in response to concerns about safety and complications. After BMP … Continue reading

Posted in Defective Medical Devices, Health Concerns, Medtonic Infuse | Tagged , , , |

Lawsuit Involving Medtronic’s InFuse Bone Graft Product Filed in St. Louis

Medtronic’s InFuse Bone Graft Product Filed in St. Louis

A group of law firms has filed a lawsuit in Circuit Court in St. Louis against Medtronic, Inc. on behalf of patients who allege injuries that include catastrophic, unchecked bone growth in the spinal column following surgical procedures with Medtronic’s … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse |

FDA Safety Warning for Bone Graft Products in Patients Under 18

FDA Warning for Bone Graft Products in Patients Under 18

The Food and Drug Administration has issued a safety alert to healthcare providers, patients, and parents and guardians that bone graft devices containing recombinant proteins or synthetic peptides should not be the first treatment considered for patients under age 18. … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse | Tagged , , , , |

Medtronic Denied Preemption in Another Device Injury Lawsuit

medtronic_denied_preemption

An Indiana appeals court just ruled that Medtronic cannot use so-called “preemption” to get out of a negligence lawsuit filed over a failed Transvene defibrillator lead. Preemption is legal concept that a number of medical device makers have used in … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Defibrillators, Medtronic Infuse |

Lawsuit Filed Against Medtronic for Promoting Off-Label Use of Infuse

medtronic_infuse_lawsuit_filed

A lawsuit filed this week alleges that Medtronic Inc. deliberately promoted the off-label use of its Infuse bone graft product. The complaint includes the names of 98 plaintiffs who allege that the off-label use of Medtronic caused them to incur … Continue reading

Posted in Medtonic Infuse |

Medtronic Issued Warning Letter Over Its Diabetes Facility

medtronic_diabetes_FDA_warning

Device maker, Medtronic Inc., was just issued a warning letter from the U.S. Food and Drug Administration (FDA) concerning its Northridge, California diabetes facility. The letter was received on September 19 and discussed procedures involving “corrective and preventative action, complaint … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.